Cardiac Surgery News and Research RSS Feed - Cardiac Surgery News and Research

CSL Behring donates protein therapies to World Federation of Hemophilia

CSL Behring donates protein therapies to World Federation of Hemophilia

In recognition of Rare Disease Day and as part of its ongoing commitment to the global bleeding disorders community, CSL Behring announced today that it is donating 2 million international units (IUs) of protein therapies to the World Federation of Hemophilia. [More]
STS releases first publicly accessible national report of surgical outcomes from CHSD

STS releases first publicly accessible national report of surgical outcomes from CHSD

Continuing its commitment to increase public awareness and understanding of cardiothoracic surgical outcomes, The Society of Thoracic Surgeons has released the first publicly accessible national report of surgical outcomes from its Congenital Heart Surgery Database (CHSD). [More]
Eight clinical researchers selected as finalists for Outstanding Investigator Award at Cardiology 2015

Eight clinical researchers selected as finalists for Outstanding Investigator Award at Cardiology 2015

Pediatric cardiology researchers and clinicians from numerous centers from around the world are gathering at the Cardiology 2015: the 18th Annual Update on Pediatric and Congenital Cardiovascular Disease conference, sponsored by The Children's Hospital of Philadelphia and Phoenix Children's Hospital on Feb. 11 to Feb. 15 in Scottsdale, Ariz. [More]
Prime Healthcare acquires St. Mary's Medical Center and St. Joseph Medical Center in Missouri

Prime Healthcare acquires St. Mary's Medical Center and St. Joseph Medical Center in Missouri

Prime Healthcare announced today that it has completed its acquisition of St. Joseph Medical Center in Kansas City, MO, and St. Mary's Medical Center in Blue Springs, MO, as well as other assets of Carondelet Health from Ascension Health. St. Joseph and St. Mary's medical centers are acute-care hospitals with 456 beds and 900 physicians on staff combined. [More]
Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Astute Medical previews upcoming AKI & CRRT 2015 conference to be held in San Diego

Astute Medical, Inc., developer of the NephroCheck® Test, today previewed the upcoming AKI & CRRT 2015 conference to be held in San Diego from February 17 to February 20. [More]
Surgical procedure for acute pulmonary embolism may actually prevent more deaths

Surgical procedure for acute pulmonary embolism may actually prevent more deaths

A surgical procedure that was virtually abandoned in the 1950s because of its high mortality rates in trying to save patients with acute pulmonary embolism may actually prevent more deaths in severely ill patients than current drug therapies alone, according to a new analysis of cases conducted in the North Shore-LIJ Health System over the past decade. [More]
Edwards Lifesciences’ net sales increase 15% to $618.0M in Q4 2014

Edwards Lifesciences’ net sales increase 15% to $618.0M in Q4 2014

Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended December 31, 2014 of $109.2 million, or $1.00 per diluted share, and non-GAAP1 net income of $116.5 million, or $1.06 per diluted share. Net income for the same period a year earlier was $75.1 million, or $0.68 per diluted share, and non-GAAP net income was $105.0 million, or $0.95 per diluted share. [More]
Jersey Shore University Medical Center offers robotic-assisted laparoscopic sleeve gastrectomy

Jersey Shore University Medical Center offers robotic-assisted laparoscopic sleeve gastrectomy

For many people, losing weight is a personal and ongoing battle. At the Center for Weight-Loss Surgery at Jersey Shore University Medical Center, new options are available for those making the life changing decision to lose weight, including minimally invasive techniques such as robotic-assisted laparoscopic sleeve gastrectomy. [More]
Astute Medical, bioMérieux sign agreement to develop NephroCheck Test for acute kidney injury

Astute Medical, bioMérieux sign agreement to develop NephroCheck Test for acute kidney injury

bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein biomarkers, today announced that they have signed a global, semi-exclusive agreement regarding the development of a test for the early risk assessment of acute kidney injury (AKI). [More]
Bayshore Community Hospital releases new Multi-specialty Interventional Suite

Bayshore Community Hospital releases new Multi-specialty Interventional Suite

Bayshore Community Hospital recently unveiled its new Multi-specialty Interventional Suite, outfitted with advanced technology capable of performing complex minimally invasive cardiovascular, endovascular, and interventional radiology procedures. [More]
FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

FDA receives IDE application for CytoSorbents' CytoSorb cardiac surgery trial

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced today that it has submitted an Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) to conduct its proposed clinical trial using CytoSorb® intra-operatively in patients undergoing complex cardiac surgery requiring the use of a heart-lung machine. [More]
STS, ESTS collaborate to help improve lung cancer care

STS, ESTS collaborate to help improve lung cancer care

A unique collaboration between The Society of Thoracic Surgeons and the European Society of Thoracic Surgery will help improve the quality of patient care by linking outcomes data on chest procedures, beginning with lung cancer surgery, according to an article in the January 2015 issue of The Annals of Thoracic Surgery. [More]

CytoSorbents starts trading on The Nasdaq Capital Market

CytoSorbents Corporation, a critical care immunotherapy company commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce deadly inflammation in critically-ill and cardiac surgery patients, announced that it will commence trading today on The Nasdaq Capital Market under its current ticker symbol "CTSO". [More]

Two studies shed new light on risks associated with blood transfusions

Two studies published in the January issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, shed new light on the prevalence of transfusion-related acute lung injury (TRALI) and transfusion-associated circulatory overload (TACO), the number one and two leading causes of blood transfusion-related deaths in the United States. [More]

Tendyne Feasibility Study: Tendyne successfully implants TMVI system in first patient

Tendyne Holdings, Inc., a privately held clinical stage medical device company, announced today that in November 2014 the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial, which aims to generate insight into the safety and performance of the Tendyne device in inoperable patients suffering from mitral regurgitation. [More]
Study: Preoperative interventions improve outcomes of patients undergoing CABG surgery

Study: Preoperative interventions improve outcomes of patients undergoing CABG surgery

A quality improvement initiative improved the outcomes of patients undergoing cardiac surgery at select medical centers in northern New England, according to a study in the December issue of Critical Care Nurse (CCN). [More]
Surgery simulator app: an interview with Jean Nehme

Surgery simulator app: an interview with Jean Nehme

Touch Surgery is a mobile surgical simulation app that allows surgeons to learn and rehearse surgical procedures. It provides a cognitive map for operations on a virtual patient. [More]
Cardio3 BioSciences announces acquisition of CorQuest Medical

Cardio3 BioSciences announces acquisition of CorQuest Medical

Cardio3 BioSciences, a leader in the discovery and development of regenerative, protective and reconstructive therapies, announces today that it has acquired U.S.-based CorQuest Medical Inc. CorQuest Medical specializes in the development of innovative devices and technologies for cardiac surgery. [More]
Robotically assisted CABG surgery reduces complications, cuts recovery times

Robotically assisted CABG surgery reduces complications, cuts recovery times

Robotically assisted coronary artery bypass grafting (CABG) surgery is a rapidly evolving technology that shortens hospital stays and reduces the need for blood products, while decreasing recovery times, making the procedure safer and less risky, says a study presented at the Canadian Cardiovascular Congress. [More]
Interrupting blood supply to limb before cardiac surgery protects the heart during operation

Interrupting blood supply to limb before cardiac surgery protects the heart during operation

In a study just published in the International Journal of Cardiology, researchers from the K.G. Jebsen Center for Exercise in Medicine – Cardiac Exercise Research Group (CERG) at the Norwegian University of Science and Technology (NTNU) and the Department of Cardiothoracic Surgery at the St. Olavs Hospital in Trondheim, Norway have shown that shutting off the blood supply to an arm or leg before cardiac surgery protects the heart during the operation. [More]